We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEBS icon
3501
Direxion Daily Dow Jones Internet Bear 3X ETF
WEBS
$7.15M
$30K ﹤0.01%
196
-185
-49% -$35.8K
WIT icon
3502
Wipro
WIT
$19.5B
$30K ﹤0.01%
7,642
-12,434
-62% -$46.4K
PAMT
3503
PAMT Corp
PAMT
$281M
$30K ﹤0.01%
2,256
+1,328
+143% +$19.2K
NXGN
3504
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$30K ﹤0.01%
1,788
-3,749
-68% -$67.2K
FRG
3505
DELISTED
Franchise Group, Inc.
FRG
$30K ﹤0.01%
853
-1,925
-69% -$70.8K
LHDX
3506
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$30K ﹤0.01%
4,402
+3,118
+243% +$19.7K
KLDO
3507
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$30K ﹤0.01%
4,015
-2,297
-36% -$16.3K
ALTA
3508
DELISTED
Altabancorp
ALTA
$30K ﹤0.01%
697
+137
+24% +$5.98K
DSSI
3509
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
$30K ﹤0.01%
3,076
-941
-23% -$9.76K
ALRS icon
3510
Alerus Financial
ALRS
$833M
$29K ﹤0.01%
1,001
-545
-35% -$17K
ANGO icon
3511
AngioDynamics
ANGO
$651M
$29K ﹤0.01%
1,079
-5,485
-84% -$134K
ASX icon
3512
ASE Group
ASX
$85B
$29K ﹤0.01%
3,580
-13,306
-79% -$107K
BFST icon
3513
Business First Bancshares
BFST
$1.04B
$29K ﹤0.01%
1,250
-157
-11% -$3.72K
BRSP
3514
BrightSpire Capital
BRSP
$626M
$29K ﹤0.01%
3,020
-2,442
-45% -$22.5K
CARM
3515
DELISTED
Carisma Therapeutics
CARM
$29K ﹤0.01%
313
-1,181
-79% -$75.3K
CCB icon
3516
Coastal Financial
CCB
$793M
$29K ﹤0.01%
1,005
+333
+50% +$9.75K
CGNT icon
3517
Cognyte Software
CGNT
$692M
$29K ﹤0.01%
1,167
-5,975
-84% -$148K
DESP
3518
DELISTED
Despegar.com
DESP
$29K ﹤0.01%
2,168
+1,328
+158% +$17.9K
EXTR icon
3519
Extreme Networks
EXTR
$3.14B
$29K ﹤0.01%
2,589
-12,006
-82% -$127K
FF icon
3520
Future Fuel
FF
$279M
$29K ﹤0.01%
3,020
+282
+10% +$3.41K
FIVN icon
3521
FIVE9
FIVN
$2.44B
$29K ﹤0.01%
158
-2,114
-93% -$364K
GB
3522
DELISTED
Global Blue Group Holding
GB
$29K ﹤0.01%
2,958
+2,858
+2,858% +$30.5K
GIFI
3523
DELISTED
Gulf Island Fabrication
GIFI
$29K ﹤0.01%
+6,431
New +$28.9K
HSII
3524
DELISTED
Heidrick & Struggles
HSII
$29K ﹤0.01%
656
-900
-58% -$37.6K
IVR icon
3525
Invesco Mortgage Capital
IVR
$802M
$29K ﹤0.01%
761
-1,948
-72% -$73.8K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.